H ypervascularization and fibrosis observed in longterm peritoneal dialysis (PD) patients are causally related to the long-term use of conventional dialysis fluids (1) . Bicarbonate-based PD solutions are buffered at neutral pH and are virtually free of glucose degradation products (GDPs) (2) . Low pH and high lactate levels, features of conventional fluids, have been shown to independently impair mesothelial cell function (3, 4) . The pH of the dialysis fluid may become particularly relevant in automated peritoneal dialysis (APD), where the peritoneal membrane is repeatedly reexposed to fresh acidic fluid (5) . Leukocyte function has also been shown to be less suppressed using bicarbonate-based PD fluids (6) (7) (8) .
The toxic effects of GDPs on viability and function of peritoneal leukocytes, fibroblasts, and mesothelial cells are now fully recognized (9) . They may also be directly involved in the pathogenesis of peritoneal hypervascularization and fibrosis by stimulating local vascular endothelial growth factor (VEGF) and transforming growth factor beta synthesis and release (10, 11) . Indeed increased vessel density was observed in animals chronically exposed to a conventional acidic dialysis solution (Dianeal; Baxter Inc, Deerfield, Illinois, USA) with a high GDP content compared with a new pH-neutral dialysis solution (Physioneal; Baxter Ltd, Castlebar, Ireland) (12) .
Another advantage of these newer fluids is decreased infusion pain, possibly associated with a higher pH (13, 14) . Improved correction of metabolic acidosis has recently been shown in children (15) .
Converting patients to bicarbonate-based fluids in the acute setting may, however, affect ultrafiltration (UF): first, due to a larger surface area available for exchange (and UF) in acidic solutions (16, 17) and, second, because of a faster dissipation of the glucose gradient (17) . In the long term, increased neovascularization in patients on conventional fluid (10-12) could also alter UF. To date there have been varied reports in the literature. In children, no difference in UF has been reported, although a larger area available for exchange has been demonstrated with acidic fluids in the acute setting (17) , making this theoretically possible. This vasodilator effect may be particularly important in children on APD with short dwell times. In adults, there have been varied reports showing either a higher UF in the chronic setting (18) , due possibly to decreased neovascularization, or a lower UF in the acute setting using bicarbonate-based fluids (19) .
In order to obtain more knowledge on UF using these fluids, we compared transcapillary ultrafiltration (TCUF) and lymphatic absorption [expressed as marker clearance (MC)] in children using a conventional acidic dialysis solution versus a pH-neutral solution. We compared these parameters using a peritoneal equilibration test (PET), with dextran 70 (Macrodex NPBI, Emmercompascuum, The Netherlands) as volume marker added to the test solution.
PATIENTS AND METHODS
Peritoneal equilibration tests were performed in 12 stable children on APD using a pH-neutral PD fluid (Physioneal) and dextran 70 (4 g/L) as volume marker.
The tests were compared with 12 tests (in 12 different patients) performed previously with an acidic solution (Dianeal). The latter patients came from a historical set of patients at the hospital who had previously had PETs done in an identical manner (as this is how all PETs are conducted in this hospital) in the pre-Physioneal era (i.e., using Dianeal). Patients were identified who matched the study group for age, time on PD, and body surface area (BSA). All patients used the same dialysis solution for their chronic dialysis, although glucose concentration varied with the UF needed. Patients using Physioneal were doing so because of a policy in this hospital to change all patients to Physioneal, as it had become available. Prior to the study, the entire Dianeal group had been using Dianeal exclusively. Six patients in the Physioneal group had been exposed to Dianeal prior to the study (see Table 1 ). None of the patients had been exposed to Extraneal (Baxter). Four patients in the Physioneal group and 6 in the Dianeal group had had peritonitis episodes. The average peritonitis incidence in the Physioneal group was 0.91 episodes per year and in the Dianeal group 0.76 episodes per year. Two patients in the Physioneal group and 4 in the Dianeal group were on antihypertensive treatment. Please refer to Table 1 for frequency of peritonitis episodes and antihypertensive drug use.
Causes of renal failure in the Physioneal group were congenital nephrotic syndrome in 2, dysplasia in 2, and autosomal recessive polycystic kidney disease, obstructive uropathy, reflux nephropathy, diffuse mesangial sclerosis, posterior urethral valves, Denys-Drash syndrome, congenital interstitial nephritis, and unknown in 1 each. In the Dianeal group, causes of renal failure were hypoplasia/dysplasia in 4, posterior urethral valves in 3, and congenital nephrotic syndrome, cystinosis, focal segmental glomerulosclerosis, reflux nephropathy, and unknown in 1 each.
PERITONEAL EQUILIBRATION TEST
In all patients, PETs were performed as described earlier (20) . A 4-hour dwell of 1200 mL/m 2 BSA of either Dianeal 3.86% or Physioneal 3.86% was studied using dextran 70, 4 g/L, as volume marker. During the study, a blood sample was drawn for determination of glucose, creatinine, and urea. Dialysate samples were taken at the start of the study and after 5, 30, 60, 120, 180, and 240 minutes for measurement of glucose, creatinine, urea, and dextran. Dextran concentrations in the samples were used for calculation of fluid kinetics, and concentrations of urea, creatinine, and glucose to calculate small solute transport rates. After drainage of the test fluid (at 240 minutes), 40 mL/kg dialysate was instilled and then drained immediately. The dextran concentration in the effluent of this fluid was used for calculation of the post-exchange residual volume. Preexchange residual volume was calculated from the initial and the 5-minute dextran concentrations (see Appendix).
In the case of a peritonitis episode, PET was performed at least 2 months after the episode.
CALCULATIONS
Fluid Kinetics: Calculations of intraperitoneal volumes, TCUF, and MC were performed as published previously (20) . Briefly, lymphatic absorption was calculated from the disappearance rate of dextran from the peritoneal cavity (MC), taking sampling into account. Transcapillary UF was calculated at each time interval from the dilution of dextran in the abdominal cavity, taking into account the disappearance of dextran by lymphatic absorption as well as by sampling. Pre-and post-residual volumes were factored in when calculating fluid kinetics. All results are expressed per 1.73 m 2 BSA. A full description of the calculation is given in the Appendix.
Solute Transport: Peritoneal transport rates of low molecular weight solutes (creatinine, urea) are expressed as dialysate concentration/plasma concentration (D/P ratios).
Glucose transport is expressed as ratio of the glucose concentration in the dialysate at the beginning of the dwell period to glucose concentration in the dialysate at time t (D t /D 0 ratio).
STATISTICAL ANALYSIS
The two groups were compared for age, time on PD, BSA, and TCUF at each of the sampling times, D/P ratios for urea and creatinine and D t /D 0 for glucose at each of the sampling times, and MC. The data were first tested for normality (Kolmogorov-Smirnov and Shapiro-Wilk). In the few cases where these tests showed significant deviations from normality, the nonparametric Wilcoxon matched-pairs test gave results similar to the repeated measures ANOVA. Thus, only the RANOVA results are presented. Differences were considered statistically significant with a p value less than 0.05.
RESULTS

AGE, TIME ON PD, AND BSA
Mean age, time on PD, and BSA of patients using Physioneal was 70 ± 48 (range 14 -183) months, 18 ± 16 (range 3 -52) months, and 0.84 ± 0.34 m 2 , respectively. Mean age, time on PD, and BSA of patients using Dianeal was 75 ± 49 (range 12 -197) months, 17 ± 14 (range 3 -49) months, and 0.82 ± 0.36 m 2 . The two groups were not statistically different with respect to these parameters.
FLUID HANDLING
Marker clearance and TCUF for the two different fluids (calculated at the different sampling times) are shown in Figure 1 . Values are given as mean and standard deviation. There was no significant difference in TCUF or MC at any of the sampling times between the two groups.
D/P RATIOS FOR UREA AND CREATININE AND D t /D 0 GLUCOSE RATIOS
There were no significant differences between the two fluids with respect to D/P or D t /D 0 ratios for urea, creatinine, and glucose [ Figure 2 ]. Values are given as mean and standard deviation. performed conventional PETs in 33 adult patients and observed a higher net UF using conventional versus bicarbonate fluids This was a crossover design, thus demonstrating differences in the acute setting. Tranaeus, however, in a long-term randomized prospective study in 106 patients, found a small but significant increase in daily net UF using bicarbonate-based fluids (18) . As the design in this study was over a year, it reflects changes in fluid handling in the chronic setting.
In children, no differences have been found to date in the acute or chronic setting. In a randomized crossover study in 25 children using a 4-hour PET and overnight cycling, Schmitt et al. could not demonstrate a difference in intraperitoneal volume or net UF (5). In another randomized crossover comparison for two consecutive 12-week periods, Haas et al. found no difference in daily net UF rates in 28 children on APD (15) . Although Fischbach et al., also in a comparative crossover study, could demonstrate a larger surface area available for exchange in their Dianeal group, there were also no differences in net UF observed (17) . These studies in children are comparing differences in the acute setting and are not comparing possible long-term benefits on peritoneal fluid handling by using bicarbonatebased fluids.
In our study, we used a higher glucose concentration and larger volumes than any of the other studies, which could have the effect of accentuating UF. The application of a high glucose concentration for the PET has been advocated in the literature as it allows for optimal study of fluid transport mechanisms (21, 22) . Our methodology also differed from the studies above: in our calculation of TCUF, we compensate for lymphatic absorption, which can be highly variable from 1 patient to another. In all the other studies, only net UF (with the exception of Schmitt's study) was used as outcome. Our methodology also allowed for calculation of TCUF at each sampling time. As in the studies by Schmitt et al., we could also not demonstrate any significant differences in small solute transport between the two groups.
What needs to be noted is that Physioneal has a combination lactate and bicarbonate buffer, so these results may not necessarily be applied to pure bicarbonate-buffered fluids. However, in the rat experiment by Mortier et al. (16) , they demonstrated that it was the GDPs that caused the vasodilatation. When pH-neutral solutions containing lactate but with minimal GDPs were used, there was minimal vasodilatation. So, although our bags have lactate, they are a double-bag system, meaning the glucose is sterilized at low pH and therefore has minimal GDPs. Not all new bicarbonate-based fluids have the same pH, which could also make a difference in the amount of vasodilatation (and hence UF) caused if acidity per se is a major factor contributing to vasodilatation (16) .
It is impossible to separate the acute effects (i.e., increased vasodilatation caused by acidic fluids) and the chronic effects (differences in neoangiogenesis and fibrosis) of the two fluids on the TCUF-versus-time curve. Our patients, however, were matched for time on PD and analyzed as matched pairs, thereby reducing the difference in chronic changes in the peritoneal membrane between the two groups. Also, previous authors have shown no difference in small solute transport creatinine clearance or TCUF in children on chronic PD up to 33 -55 months (23) (24) (25) . As the longest time on PD was 52 months, it is unlikely that any long-term effects on the peritoneal membrane had yet taken place.
Because of the proven vasodilator effect of acidic fluid in the acute setting, there must be subtle differences in fluid handling between acidic and pH-neutral fluids. We, however, could find no significant differences during 4-hour PETs. Patients can thus be safely converted to these more biocompatible fluids without expecting substantial changes in ultrafiltration.
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APPENDIX
Marker clearance (MC) was defined as the difference between the amount of dextran instilled and the amount recovered, divided by the product of the dwell time and the mean dextran concentration [(C5 × C240) 1/2 ]. It was assumed that MC is a linear process. The following formula was used, where Vi is the volume, Ci is the dextran concentration of the test bag, V240 is the drained volume of the test bag, RVpost is the calculated post-exchange residual volume, Ct is the dextran concentration at time t, and S is the sample volume: The amount of dextran in the peritoneal cavity was divided by its concentration to calculate intraperitoneal volume (IPVt). The calculations of IPV0, IPV30, and IPV60 are shown below. IPV120, IPV180, and IPV240 were calculated in a similar way. The theoretical intraperitoneal volume (TIPVt), that is, the intraperitoneal volume in the absence of MC and sampling, was determined by adding the cumulative sample volume (St) and MC: TIPVt (mL) = IPVt + St = MC × t.
